CA-3E
16.11.2023 15:01:34 CET | Business Wire | Press release
Headquartered in Europe with a global reach, Chemycal’s suite of software and data solutions enable global enterprises to navigate the ever-evolving regulatory backdrop by making complex chemical and product management decisions in a more informed and confident manner. Chemycal supports the creation of safer and more sustainable products by providing essential compliance tools and intelligent information, including global regulatory news tracking and 360-degree monitoring of regulatory updates, that highlight the impact of local changes on a company’s global portfolio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231113229200/en/
“Chemycal’s offerings cover critical aspects of a customer’s regulatory monitoring activities, from reporting real-time news to delivering actionable product-level insights,” said Greg Gartland, Chief Executive Officer of 3E. “Chemycal’s ability to help global corporations track and comply with increasingly complex regulations aligns with 3E’s purpose to enable a safer, more sustainable world. We look forward to introducing Chemycal’s industry-leading platform and content to our over 5,000 customers globally.”
Heightened regulatory pressures have led to growing customer demand for efficient and reliable compliance solutions. The combined content and coverage from 3E and Chemycal responds to this market need. Chemycal's broad monitoring and content coverage from more than 1,500 regulatory sources, alongside 3E's broad regulatory data and substance coverage, will provide enhanced global horizon scanning capabilities for clients.
Luca Mohammadi, Co-Founder and CTO of Chemycal, said, “We are thrilled to be joining 3E, a company that shares our vision for providing businesses with the vital data, intelligence, and tools to ensure their products can move safely through the value chain to protect people and the environment. Joining 3E will provide our customers an end-to-end suite of global monitoring products to realize our shared vision.”
“We’re excited to join 3E and bring our platforms to a larger audience,” added Lorenzo Zullo, Co-Founder and CEO of Chemycal. “We have found in 3E a leadership team with the necessary passion, scale and resources to further accelerate Chemycal’s impressive historical growth. We share the same vision to better support global industries to address emerging regulatory challenges. Coupling our scalable platform with 3E’s deep regulatory domain expertise creates a powerful combination, which will empower our customers to consistently achieve their compliance goals.”
Chemycal represents 3E’s third acquisition announcement since its separation from Verisk in March 2022.
Shearman & Sterling LLP served as the legal advisor to 3E. Cambrian served as the legal advisor to Chemycal.
About Chemycal
Founded in 2015, Chemycal is a global regulatory monitoring company, pairing advanced software and technology with domain expertise to aggregate chemical and product compliance data. Leveraging its worldwide network of 1,500 sources, the Company maintains a deep library of 35,000+ news summaries and 150,000+ substances and materials, keeping customers up to date with real-time developments relevant to their product portfolio via its advanced content management system and machine learning algorithms. Clients around the world trust Chemycal with the compliance of their products and the continuity of their businesses.
About 3E
For more than 35 years the world’s leading companies have trusted 3E to provide the intelligent compliance solutions they need to ensure safety and sustainability. Unmatched Environmental, Health, Safety and Sustainability (EHS&S) and product compliance expertise empowers clients to improve chemical and workplace safety, product safety and stewardship and supply chain transparency. 3E is deeply committed to serving its more than 5,000 customers worldwide, representing a wide variety of industries and including the world’s largest chemical manufacturers, retailers and pharmaceutical companies. Learn more at www.3Eco.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231113229200/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Goku Technologies Chooses SS&C for Fund Services2.9.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Singapore Goku Technologies Pte. Ltd., an AI-driven quantitative investment manager, has chosen SS&C as its fund services provider. The firm, with offices in Shanghai and Singapore, employs systematic trading strategies to invest in equities across Asia, with USD4 billion in assets under management. SS&C GlobeOp will provide fund administration services for the Goku Technologies Master Fund. The fund operates a high-volume trading strategy with substantial daily trading activity. SS&C will support the fund through a comprehensive suite of services including fund accounting and investor services, helping Goku Technologies build a scalable operating model. “As our business has grown, so have our demands on our trading and operational framework,” said Ken Chung, CEO of Singapore Goku Technologies. “We are building an institutional quality operations infrastructure, so we needed a provider capable of supporting a high-vol
Boomi Delivers the Critical Infrastructure That Brings Control to Enterprise AI2.9.2026 03:00:00 CEST | Press release
Govern AI agents, optimize token spend, and mitigate security risk to operationalize AI at scale Boomi, the data activation company for AI, today announced major platform innovations designed to solve critical barriers to enterprise AI adoption. At the core of these updates is Boomi’s Agent Control Plane, AI-native infrastructure that securely connects AI agents to core business systems, provides governance over agent activity, and controls runaway AI costs. This critical infrastructure runs flexibly across public cloud, the customer’s own cloud (VPC), or on-premises, directly supporting data and digital sovereignty, and giving organizations greater operational control over their AI estate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901851538/en/ Boomi Delivers the Critical Infrastructure That Brings Control to Enterprise AI Key Takeaways Boomi’s Agent Control Plane provides the critical AI-native infrastructure that
Meraki Capital Launches Tessero Across Six European Markets Following Landmark Hays Acquisition1.9.2026 22:36:00 CEST | Press release
Meraki Capital has launched Tessero,a new European specialist recruitment group created from the six former Hays plc businesses it acquired earlier this summer. Launching simultaneously across Sweden, Denmark, Hungary, Romania, Luxembourg and Czechia, Tessero brings six established recruitment businesses together under one independent European brand, creating an international platform with experienced teams, existing clients and active candidate networks from day one. The launch follows one of the most significant transactions in Meraki Capital’s history and the completion of a major transition programme across all six countries within weeks of the acquisition. 130 employees will now operate under the Tessero brand, with established country leadership teams remaining in place and continuing to lead their respective markets. Gary Elden OBE, CEO of Meraki Capital and Director of Tessero, said: “Tessero launches with something that normally takes years to build: established businesses, ex
SBC Medical to Participate in Several Upcoming Investor Conferences in September 20261.9.2026 19:35:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in September 2026. SBC Medical will conduct presentations and one-on-one meetings with institutional investors. Below is a summary of the Company’s scheduled participation in upcoming investor conferences: H.C. Wainwright 28th Annual Global Investment Conference Date: September 14 2026 Format: In-person (NY) Registration: https://my.ct.events/register.aspx?meid=cff43623-9e9f-45d4-bbc3-ee19e9c372c1&rpid=a667ca45-171e-4306-98eb-c466e8b7e6c1 ArcStone Kingswood Growth Summit 2026 Date: September 16 2026 Format: In-person (Toronto) Registration:https://www.meetmax.com/sched/event_144037/investor_reg_new.html?attendee_role_id=ARCSTONE_ATTENDEE CLSA 33rd Investors’ Forum 2026 Date: September 21, 2026 Format: In-person (Hong K
Crimson Moon Available Now, Bringing Heavy-Metal Gothic Action to Solo and Co-op Players on PC, PlayStation 5, and Xbox Series X|S1.9.2026 19:00:00 CEST | Press release
ProbablyMonsters’ action-adventure RPG offers blood-soaked combat, monstrous showdowns, and deep replay value for $19.99 USD ProbablyMonsters, an independent video game company creating original AA games with AAA sensibilities, today launched Crimson Moon on PC via Steam and Epic Game Store, PlayStation 5, and Xbox Series X|S for $19.99 USD. A $29.99 USD Deluxe Edition is also available and includes an exclusive armor set, weapon cosmetic, and upcoming game expansion. Watch the official Crimson Moon launch trailer on YouTube to see the game’s gothic heavy-metal power fantasy, crafted for both solo and co-op players, in action. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901064893/en/ Crimson Moon is a gothic high renaissance action-adventure RPG built around intense, replayable missions that blend brutal precision with deep character progression. Players take on the role of the Nephilim, powerful human-angel hybrids bo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
